Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit


U.S. Preventive Services Task Force Makes Recommendations on Prostate Cancer Screening

Nowadays, a strategy called active surveillance is often used. This is a “wait and see” approach. Men have regular checkups with their doctor, but treatment doesn’t start unless and until necessary.

“Prostate cancer is one of the most common cancers to affect men and the decision whether to be screened is complex,” said Task Force vice chair Alex H. Krist, MD, MPH in a press statement. “Men should discuss the benefits and harms of screening with their doctor, so they can make the best choice for themselves based on their values and individual circumstances.”

For more information on prostate cancer and screening, please see these links:

Prostate Cancer (overview)

Understanding the Effects of Biopsies and Prostatectomy

Prostate Cancer and Sex: Questions to Consider

Note: In 2013, the American Urological Association (AUA) set forth these guidelines on prostate cancer screening, which were reviewed and validity confirmed in 2015:

  • PSA screening is not recommended in men younger than 40 years.
  • Routine screening is not recommended for men between the ages of 40 and 54 who are at average risk for prostate cancer.
  • Men between the ages of 55 and 69 should undergo “shared decision-making” about PSA screening “based on a man’s values and preferences.”  For men who decide to proceed, screening conducted every two years (or longer, if appropriate) may be preferred over annual screening.
  • PSA screening is not recommended in men age 70 or over or in men with a life expectancy of less than 10 to 15 years.


American Urological Association

“Early Detection of Prostate Cancer”
(Published 2013; Reviewed and Validity Confirmed 2015)

U.S. Preventive Services Task Force

“Frequently Asked Questions”

(May 2018)

“Is Prostate Cancer Screening Right for You?”

(May 2018)

“U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Prostate Cancer”

(News statement. May 8, 2018)

« Previous 1 2 3 (page 3 of 3)